Abstract:s Objective Lymphedema is a common complication of cancer treatment such as lymphadenectomy and radiation therapy. It is a debilitating condition with pathologic tissue changes that hinder effective curative treatment and jeopardize patients' quality of life. Various attempts to prevent the development of lymphedema have been made with improvements in the incidence of the pathology. However, it is still prevalent among cancer survivors. In this paper, we review both molecular therapeutics and immediate surgical lymphatic reconstruction as treatment strategies after lymphadenectomy. Specifically, we discuss pro-lymphangiogenic molecules that have proved efficacy in animal models of lymphedema and clinical trials, and review currently available microsurgical techniques of immediate lymphatic reconstruction. Methods A literature search was conducted in PubMed, Embase, Cochrane library, and Google Scholar through May 2022. Searches were done separately for molecular therapeutics and microsurgical techniques for immediate lymphatic reconstruction. Search terms used for (1) non-surgical methods include 'lymphangiogenesis', 'lymphedema', 'growth factor', and 'gene therapy'. Search terms used for (2) surgical methods include 'lymphedema', 'lymph node excision', 'lymphatic vessels', 'primary prevention', and 'microsurgery'. Results Various pro-lymphangiogenic factors with therapeutic potential include VEGF-C, VEGF-D, HGF, bFGF, PDGF, IGF, Retinoic acid, Ang-1, S1P, TLR4, and IL-8. Microsurgical lymphatic reconstruction for prevention of secondary lymphedema includes lymphovenous anastomosis (LYMPHA), vascularized lymph node flap transfer, and lymph-interpositional flap transfer (LIFT), with promising clinical outcomes. Conclusions With growing knowledge of the lymphangiogenic pathway and lymphedema pathology and advances in microsurgical techniques to restore lymphatic channels, molecular and surgical approaches may represent a promising method for primary prevention of lymphedema.

Histopathologic Features of Lymphedema: A Molecular Review

Pathophysiology and Molecular Research in Lymphedema

Secondary lymphedema: Pathogenesis

Lymphatic Collecting Vessels in Health and Disease: A Review of Histopathological Modifications in Lymphedema

The Unresolved Pathophysiology of Lymphedema

Lymphedema and subclinical lymphostasis (microlymphedema) facilitate cutaneous infection, inflammatory dermatoses, and neoplasia: A locus minoris resistentiae

Secondary Lymphedema: Clinical Interdisciplinary Tricks to Overcome an Intriguing Disease

The Future of Lymphedema: Potential Therapeutic Targets for Treatment

A Narrative Review of Pathogenesis and Opportunities for Therapeutic Intervention

Pharmacological Treatment of Secondary Lymphedema

Acquired lymphedema: Molecular contributors and future directions for developing intervention strategies

Regulation of Immune Function by the Lymphatic System in Lymphedema

Lymphatic Dysfunction, Leukotrienes, and Lymphedema

A Comparative Analysis to Dissect the Histological and Molecular Differences among Lipedema, Lipohypertrophy and Secondary Lymphedema

Progress in lymphedema

Review of treatment strategies after lymphadenectomy: From molecular therapeutics to immediate microsurgical lymphatic reconstruction

Complex Lymphatic Anomalies: Molecular Landscape and Medical Management

The lymphatics and the inflammatory response: lessons learned from human lymphedema

Therapeutic Lymphangiogenesis Is a Promising Strategy for Secondary Lymphedema

Lymphatic Endothelial Cells, Lymphedematous Lymphangiogenesis, and Molecular Control of Edema Formation

The Roles of Podoplanin-Positive/Podoplanin-Negative Cells from Adipose-Derived Stem Cells in Lymphatic Regeneration